CVE-2026-10109
Multiple vulnerabilities have been discovered in IBM products. Some of them allow an attacker to cause remote arbitrary code execution, privilege escalation, and remote denial of service.
CSIRTS triage
- What
- Multiple vulnerabilities in IBM products can lead to remote code execution and privilege escalation.
- Who is affected
- Users of affected IBM products.
- Urgency
- Immediate action is required due to the severity of the vulnerabilities.
- Action
- Update IBM products to the latest versions to mitigate these vulnerabilities.
AI-assisted analysis generated from the source advisory — verify against the original.
⚡ Watch CVE-2026-10109
Get an email if CVE-2026-10109 is added to CISA KEV, gains public exploit code, or a new advisory cites it — max one per day, one-click unsubscribe.
Exploitation outlook
- Low exploitation risk0.86% 30-day exploitation probability — currently an unlikely target, but scores change as exploit code circulates. Riskier than 54% of all EPSS-scored CVEs.
Advisory coverage (2)
- criticalCVE-2026-10109: IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.4 is vulnerable to remote code executio…nvd · 2026-06-30
- unknownMultiple vulnerabilities in IBM products (June 26, 2026)cert-fr-avis · 2026-06-26
External references
Embed the live status
— this badge updates automatically when the KEV or exploit status changes. How to embed it →
[](https://www.csirts.com/cve/CVE-2026-10109)